Most Recent
Millennium wins injunction against Juno over generic cancer drug
US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer drug Velcade in Australia.
AstraZeneca challenges landmark sick leave case
AstraZeneca is appealing a Fair Work Commission decision that workers are guaranteed 10 days' sick leave under the National Employment Standards regardless of how long their working day is.
Nurofen superiority claims breached consumer law, Full Court affirms
The Full Federal Court has shot down Reckitt Benckiser's appeal of a ruling that it misled consumers with claims that its Nurofen is a more effective pain killer than rival GlaxoSmithKline's Panadol.
Full Court shrinks class size in Ethicon pelvic mesh class action
The Full Federal Court has handed Johnson & Johnson unit Ethicon a victory in the class action over its allegedly defective vaginal mesh devices, partly reversing a judge's decision that expanded the class post-trial.
Dr. Reddy’s slams Millennium’s injunction bid in cancer drug case
An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy's Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.
Sanofi launches patent case over Alphapharm injector pen
Global pharmaceutical giant Sanofi-Aventis has launched patent infringement proceedings against generic drug maker Alphapharm seeking "urgent interlocutory relief" to prevent a generic injector pen from being listed on the market.
Parties in AMS pelvic mesh class action promise streamlined approach
Lawyers on both sides of the class action against American Medical Services over pelvic mesh implants have taken steps to ensure the case proceeds with greater efficiency than the pelvic mesh class action against Johnson & Johnson, which went to an 89-day trial five years after that case was filed.
Judge overlooked crucial evidence in Nurofen case, Full Court hears
A Federal Court judge skipped vital witness testimony when he ruled Reckitt Benckiser misled consumers about the effectiveness of its Nurofen painkiller, the pharmaceutical company told the Full Federal Court Monday.
Patent suits launched over breakthrough cancer drug
Two patent infringement lawsuits have been launched over attempts to sell generic versions of breakthrough cancer drug Velcade in Australia, after a US court last year struck down attempts to invalidate a patent for the drug.
Pharmacist who sold fake Viagra can’t get licence back
A Sydney pharmacist who was stripped of his registration after selling counterfeit Viagra has lost an application to have his licence reinstated.